undefined

Lori Riley

Chief Operating Officer at PhRMA (Pharmaceutical Research and Manufacturers of America) and healthcare policy expert; appears to explain PBM reform, FTC actions, and impacts on drug pricing.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app